Q2 Round Up: You Can’t Always Get What You Want

Q2 Round Up

You Can’t Always Get What You Want

In a year marked by persistent uncertainty and cautious optimism, the second quarter of 2025 offered a revealing snapshot of the biopharma sector’s resilience and adaptability. While the industry continues to navigate macroeconomic headwinds,...Contents

Foreword

Second Quarter M&A Activity Looks Like More Of The Same, Mostly

IPO Update: With Just Two Small Offerings In Q2, What’s Next?

Venture Funding Plummets In Q2 As Mega-Rounds Falter

China’s Biotechs Were The Small-Cap Rising Stars In H1 2025

China’s Mid-Cap Companies Thriving On Big Pharma Deals

Thank you for reading Q2 Round Up: You Can’t Always Get What You Want